Ghaderi A - Search Results

1

KIRs gene content diversity in Iranians with urothelial bladder cancer.

Jamali E, Barani S, Yousefinejad F, Ariafar A, Talei GR, Ghaderi A. Jamali E, et al. Among authors: ghaderi a. Mol Biol Rep. 2018 Oct;45(5):713-719. doi: 10.1007/s11033-018-4221-9. Epub 2018 Jul 2. Mol Biol Rep. 2018. PMID: 29968117

2

KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians.

Barani S, Khademi B, Ashouri E, Ghaderi A. Barani S, et al. Among authors: ghaderi a. Hum Immunol. 2018 Apr;79(4):218-223. doi: 10.1016/j.humimm.2018.01.012. Epub 2018 Feb 9. Hum Immunol. 2018. PMID: 29408295

3

Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients.

Hematian Larki M, Barani S, Talei AR, Ghaderi A. Hematian Larki M, et al. Among authors: ghaderi a. Genes Immun. 2020 Dec;21(6-8):380-389. doi: 10.1038/s41435-020-00117-1. Epub 2020 Nov 30. Genes Immun. 2020. PMID: 33257819

4

KIR-HLA gene diversities and susceptibility to lung cancer.

Hematian Larki M, Ashouri E, Barani S, Ghayumi SMA, Ghaderi A, Rajalingam R. Hematian Larki M, et al. Among authors: ghaderi a. Sci Rep. 2022 Oct 14;12(1):17237. doi: 10.1038/s41598-022-21062-1. Sci Rep. 2022. PMID: 36241658 Free PMC article.

5

Activating and inhibitory killer cell immunoglobulin like receptors (KIR) genes are involved in an increased susceptibility to colorectal adenocarcinoma and protection against invasion and metastasis.

Barani S, Hosseini SV, Ghaderi A. Barani S, et al. Among authors: ghaderi a. Immunobiology. 2019 Sep;224(5):681-686. doi: 10.1016/j.imbio.2019.06.002. Epub 2019 Jun 20. Immunobiology. 2019. PMID: 31248612

6

Positive association of Bx genotype, KIR2L5, KIR2DS5 and full-length KIR2DS4 with the risk of meningioma.

Barani S, Taghipour M, Ghaderi A. Barani S, et al. Among authors: ghaderi a. Immunobiology. 2020 Mar;225(2):151900. doi: 10.1016/j.imbio.2019.151900. Epub 2019 Dec 19. Immunobiology. 2020. PMID: 31899050

7

Elevated IL-37 Serum Levels in Patients with Transitional Cell Carcinoma of Bladder.

Haghshenas MR, Hosseini SR, Fattahi MJ, Malekzadeh M, Ariafar A, Ghaderi A. Haghshenas MR, et al. Among authors: ghaderi a. Iran J Immunol. 2021 Dec;18(4):346-353. doi: 10.22034/IJI.2021.92669.2167. Iran J Immunol. 2021. PMID: 34931620 Free article.

8

Killer Cell Immunoglobulin-Like Receptors (KIRs) Genotype and Haplotype Analysis in Iranians with Non-Melanoma Skin Cancers.

Yousefinejad F, Jowkar F, Barani S, Jamali E, Mahmoudi E, Ramezani A, Mahmoudi Maymand E, Ghaderi A. Yousefinejad F, et al. Among authors: ghaderi a. Iran Biomed J. 2019 Sep;23(5):330-7. doi: 10.29252/.23.5.330. Epub 2019 May 19. Iran Biomed J. 2019. PMID: 31103021 Free PMC article.

9

KIR2DS4, KIR2DL2, and KIR2DS4del are linked with basaloid tumors, lymph node metastasis, advanced stage and metastatic risk in head and neck squamous cell carcinoma.

Barani S, Khademi B, Ghaderi A. Barani S, et al. Among authors: ghaderi a. Exp Mol Pathol. 2020 Feb;112:104345. doi: 10.1016/j.yexmp.2019.104345. Epub 2019 Nov 18. Exp Mol Pathol. 2020. PMID: 31751561

10

Clinical relevance and prognostic significance of PD-1/PD-Ls in non-metastatic bladder cancer: A role for PD-L2.

Ariafar A, Ghaedi M, Rezaeifard S, Shahriari S, Zeighami S, Ghaderi A, Faghih Z. Ariafar A, et al. Among authors: ghaderi a. Mol Immunol. 2020 Aug;124:35-41. doi: 10.1016/j.molimm.2020.05.010. Epub 2020 Jun 5. Mol Immunol. 2020. PMID: 32512320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters